Revance Therapeutics (RVNC) Revenue (2014 - 2024)
Revance Therapeutics (RVNC) revenue from Mar 31, 2014 to Sep 30, 2024. The TTM Revance Therapeutics (RVNC) revenue is $257M. You can adjust inflation or export chart.
Annual Revenue
Quarterly Revenue
Revance Therapeutics (RVNC) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +25.83% |
| 3 Years TTM | +59.79% |
| 5 Years TTM | +215.65% |
| 10 Years TTM | +95.20% |
| All Time TTM | +102.14% |
Annual Revenue change of Revance Therapeutics (RVNC)
| Year | Revenue | Change |
|---|---|---|
| 2024 | $177M | -24.28% |
| 2023 | $234M | +76.54% |
| 2022 | $133M | +70.40% |
| 2021 | $78M | +407.50% |
| 2020 | $15M | +3639.02% |
| 2019 | $410K | -89.01% |
| 2018 | $3.73M | +1334.62% |
| 2017 | $260K | -13.33% |
| 2016 | $300K | N/A |
| 2015 | $300K | -21.05% |
| 2014 | $380K | N/A |
Comparison Revance Therapeutics (RVNC) five years revenue CAGR with competitors
Revance Therapeutics (RVNC) five years revenue CAGR is 216.35%.